SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Takeda Pharmaceutical Co. Ltd. and Envoy Therapeutics Form Schizophrenia Research Alliance; Takeda Will Make $3 Million Plus $2.25 Million Each Year